Earnings Outlook For FibroGen
Earnings Outlook For FibroGen
It's worth noting for new investors that guidance can be a key determinant of stock price movements.FibroGen (NASDAQ:FGEN) will release its quarterly earnings report on Tuesday, 2024-11-12. Here's a brief overview for investors ahead of the announcement.
FibroGen（納斯達克：FGEN）將於2024年11月12日星期二發佈季度業績。以下是發佈之前投資者的簡要概況。
Analysts anticipate FibroGen to report an earnings per share (EPS) of $-0.30.
分析師預計FibroGen將報告每股收益（EPS）爲-0.30美元。
The announcement from FibroGen is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
市場熱切期待FibroGen的公告，投資者期待超越預期的消息和對下一季度有利的指引。
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
值得注意的是，對於新投資者來說，指導可能是股票價格波動的關鍵因素。
Earnings Track Record
歷史業績追蹤
Last quarter the company beat EPS by $0.10, which was followed by a 4.55% increase in the share price the next day.
上一季度公司每股收益超出0.10美元，隨之第二天股價上漲了4.55%。
Here's a look at FibroGen's past performance and the resulting price change:
以下是FibroGen過去的業績表現和相應的股價變動：
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.26 | -0.42 | -0.42 | -0.68 |
| EPS Actual | -0.16 | -0.33 | -0.57 | -0.52 |
| Price Change % | 5.0% | 18.0% | 15.0% | -1.0% |
| 季度 | 2024年第二季度 | Q1 2024 | 2023年第四季度 | 2023年第三季度 |
|---|---|---|---|---|
| 每股收益預估值 | -0.26 | -0.42 | -0.42 | -0.68 |
| 每股收益實際值 | -0.16 | -0.33 | -0.57 | -0.52 |
| 價格變更% | 5.0% | 18.0% | 15.0% | -1.0% |
Performance of FibroGen Shares
fibrogen股票表現
Shares of FibroGen were trading at $0.323 as of November 08. Over the last 52-week period, shares are down 31.24%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.
截至11月08日，fibrogen股票交易價爲0.323美元。在過去的52週中，股價下跌了31.24%。考慮到這些收益通常是負面的，長期股東可能會因即將公佈的業績而感到不滿。
To track all earnings releases for FibroGen visit their earnings calendar on our site.
要追蹤fibrogen的所有業績發佈，請訪問我們網站上的業績日曆。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文是由Benzinga的自動內容引擎生成，並由編輯審核。
譯文內容由第三人軟體翻譯。
